News

U.K. study: HPV vaccine reduced cervical cancer rates by 87% in women who were vaccinated at 12 and 13 03:48. The maker of an at-home cervical cancer screening test said Friday it has won approval ...
South Africa has approved the first mpox diagnostic test, bolstering efforts to improve testing access across the globe. Image: . Se-Anne Rall/IOL ...
FDA Approves First At-Home Test for Cervical Cancer Screenings Teal Health's less invasive alternative to traditional pap smears may help close screening gaps.
The Food and Drug Administration on Friday approved the first at-home test to screen for cervical cancer, Teal Health, which makes the test kit, said.. Currently, cervical cancer screening is done ...
This means mpox antigen and antibody rapid test kits, including self-test kits, are not recommended for use. For more details on the regulatory requirements for mpox diagnostics, go to Issue No ...
A home test could be the thing that alerts those at risk of cervical cancer that they need to get to a doctor, said Dr. Sarah Kim, a gynecologic surgeon at Memorial Sloan Kettering Cancer Center.
The US Preventive Services Task Force recommends screening for cervical cancer with cervical cytology – also known as a Pap test or Pap smear – every three years for women ages 21 to 29. For ...
First at-home test kit for cervical cancer approved by the FDA, company says. Previous test kits allowed women to collect their own samples but had to be performed at a health clinic.
The maker of an at-home cervical cancer screening test said Friday it has won approval from the Food and Drug Administration, giving patients an alternative to in-clinic pap smears.
First at-home test kit for cervical cancer approved by the FDA, company says. Previous test kits allowed women to collect their own samples but had to be performed at a health clinic.
On Friday, a San Francisco-based startup received FDA approval for the first-ever at-home cervical cancer test.. The company, named Teal Health, was founded in 2020 and has raised $23 million.The ...